SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
VVUS: VIVUS INC. (NASDAQ)
An SI Board Since September 1997
Posts SubjectMarks Bans Symbol
23519 69 0 VVUS
Emcee:  Frostman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
23294Up 34% in three months since your one-liner. Bad call, or have you got additiscaram(o)uche-1/21/2011
23293when are the VVUS longs gonna finally get it????Brasco One-1/21/2011
2329242% in two months. Bad call, or have you got additional guidance?scaram(o)uche-12/16/2010
23291Appears, to me, that the Endocrinologic and Metabolic Drugs Advisory Committee hscaram(o)uche-12/7/2010
23290FWIW, JPM thinks the CRL is relatively benign, and that approval is plausible intuck-10/29/2010
23289Niiiiiiiiiiiiiiiice! Next op.scaram(o)uche-10/29/2010
23288Hey, Cary. 1. Schedule 4 is and has been expected. Phentermine is 4. Lots ofscaram(o)uche-10/29/2010
23287Diet drugs have been immolated without exception in this FDA. Not friendly to intom pope-10/28/2010
23286finance.yahoo.com A glimmer of hope for VVUS in this late news release......butArthur Radley-10/28/2010
23285vvus has never had anything; dont be fooled in investing here!!Brasco One-10/14/2010
23284online.wsj.com Israel-based Teva has tentative approval from the U.S. Food and scaram(o)uche-10/5/2010
23283managed well for the shareholder..... finance.yahoo.com finance.yahoo.com (buscaram(o)uche-10/5/2010
23282>> Nearly two years of burn in the bank? << <i>3.9m in sales scaram(o)uche-10/5/2010
23281Catching up on VVUS, haven't looked at them in <i>decades</i>. scaram(o)uche-9/29/2010
23280Qnexa 2-yr study data out this am. Looks good per the PR. Looks to me like panelfred hayes-9/21/2010
23279FDA Panel Vote Against Vivus Brings More Obesity Drug Questions Date : 07/16/20mlkr17/19/2010
23278VVUS $4.96 after testing day's low @4.69! Where is the support level? GLLsmlkr-7/19/2010
23277FDA VVUS panel 7 Yes votes for approval, 9 No votes against approval, 0 abstainJack Hartmann17/15/2010
23276minyanville.com 8:07 Eric Coleman, M.D. is getting started. Giving background oJack Hartmann17/15/2010
23275My experience has been that holding through FDA meetings is the way to perditiontom pope27/14/2010
23274thestreet.com Fuerstein chimes in on the FDA meeting tomorrow.......he thinks tArthur Radley-7/14/2010
23273reuters.com Interesting time line for obesity drugs.Arthur Radley-7/13/2010
23272Vivus (VVUS) +22.5% premarket after the FDA posts briefing documents for its keyJack Hartmann-7/13/2010
23271Are the VVUS papers out?tom pope-7/12/2010
23270Thanks for posting that, finally got around to reading it. Would have read it sofred hayes-7/12/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News